Physician profile
Sarah E Grady
NPI 1215414172
$943.69
in general payments reported to CMS, 2019-2025
17 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $202 · 2023: $136 · 2024: $188 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $233.96 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $195.26 | 2022-2024 | Jornay Pm |
| Tris Pharma INC | $63.24 | 2021-2025 | Onyda Xr |
| Glaxosmithkline, LLC. | $58.34 | 2021-2023 | Bexsero |
| Organon LLC | $57.76 | 2023-2025 | Nexplanon |
| Takeda Pharmaceuticals U.S.A., INC. | $57.07 | 2021-2022 | |
| Sanofi Pasteur INC. | $44.16 | 2022-2025 | |
| Philips North America LLC | $44.14 | 2024 | (6554) Peripheral Vascular Undivided |
| Merck Sharp & Dohme LLC | $35.54 | 2024-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Collegium Pharmaceutical, INC. | $32.37 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $20.04 | 2024 | |
| Genentech USA, INC. | $18.36 | 2021 | |
| Cranial Technologies, INC | $17.75 | 2021 | |
| Cipher Pharmaceuticals US LLC | $17.59 | 2025 | Spinosad, Natroba |
| Pfizer INC. | $17.10 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $15.76 | 2023 | Methylphenidate Hydrochloride |
| Neos Therapeutics, LP | $15.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Grady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.